GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS)
$0.0545 0.0003 (0.5535%)
Analysed GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) News Sources
Genflow surges 14% as animal health giants circle canine ageing gene therapy
28-04-2026
proactiveinvestors.com
Genflow Biosciences PLC Announces Final Results
30-04-2026
yahoo.com
Genflow Biosciences PLC Announces Exercise of Warrants and Issue of Equity
08-05-2026
yahoo.com
Genflow Biosciences PLC Announces Notice of AGM
04-06-2026
yahoo.com
Genflow Biosciences PLC - Company to present at Animal Longevity Summit 2026
17-06-2026
yahoo.com
Genflow Biosciences PLC Announces Participation at BIO International Convention 2026
22-06-2026
yahoo.com
SIRT6 gene therapy shows promise in aged dogs - ICYMI
27-06-2026
proactiveinvestors.com
Genflow Biosciences PLC Announces Result of AGM
29-06-2026
yahoo.com
Genflow Biosciences PLC Announces Mid-Year Operational and Corporate Summary
13-07-2026
yahoo.com
Genflow Biosciences dog trial continues to show longevity improvements
13-07-2026
proactiveinvestors.com
What is the current price of GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS)?
The current price of GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) is $0.0545.
GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) since the previous trading day is $0.0003.
GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) since the previous trading day is 0.5535%.
What is the most recent average sentiment score for GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS)?
The most recent average sentiment score for GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) is 71 out of 100.
What is the most recent average sentiment for GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS)?
The most recent sentiment for GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) is .
SEC-8K** Filing Available For GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.